Another retrospective analysis of patients on acid suppression (H2-PPIs-both) found they had 2.5 times the risk of complications, and almost 5 times the risk of death with Cdiff, compared to those not on these medications (abstract). As such, the FDA has now issued a MedSafety warning on the risk, and advocating using the lowest dose for the shortest time possible (FDA site)
Share This Post
Categories
Related Posts
Do you have a stack of journals piling up on your desk, beside your bed or in your email inbox? In 1950, medical knowledge was estimated to double every 50 years, but now the doubling time is every few months. At this rate, it is impossible to keep up with the literature, but a group […]
This large systematic review found rectal NSAIDs significantly reduced the risk of post-ERCP pancreatitis compared to pancreatic duct stents (abstract).
This large population-based cohort found the most common causes of drug induced liver injury to be augmentin and diclofenac, followed by herbal and nutritional supplements (abstract).
Leave A Comment